We are a globally established biotechnology or life sciences company with headquarters in [Europe / Asia / EMEA / LatAm], and an ambitious roadmap for growth in the United States. As we expand our clinical, regulatory, and commercial operations across North America, we are seeking a mission-driven Chief Medical Officer (CMO) to lead U.S. medical strategy, ensure clinical and scientific excellence, and serve as a key liaison between global R&D and U.S. execution.
The Chief Medical Officer will serve as the company’s senior-most medical leader in the U.S., providing strategic oversight of clinical development, medical affairs, regulatory engagement, and safety. This executive will ensure that all U.S. activities meet the highest scientific, ethical, and regulatory standards while accelerating progress from bench to bedside. The ideal candidate combines medical credibility with business fluency and thrives in fast-paced, cross-functional environments.
Lead U.S. clinical strategy across all phases of development. Ensure alignment between global R&D priorities and local execution.
Build and manage the U.S. medical affairs function, including MSL teams, KOL engagement, publication planning, and scientific communications.
Act as medical lead in interactions with the FDA and other U.S. regulatory bodies. Ensure all clinical and promotional activities meet U.S. compliance standards.
Oversee pharmacovigilance and safety reporting in accordance with U.S. laws and industry best practices.
Partner with Clinical, Regulatory, Commercial, and Market Access teams to support product positioning, label optimization, and go-to-market readiness.
Hire, mentor, and lead a high-performing team of physicians and scientists. Foster a collaborative, data-driven, and ethically grounded culture.
Serve as external spokesperson with the scientific and medical community in the U.S., including KOLs, academic partners, and healthcare providers.
15+ years in senior medical roles within the U.S. biotech, pharma, or clinical research sectors
M.D. (or equivalent); board certification and active medical license strongly preferred
Demonstrated success in leading clinical development, regulatory strategy, or medical affairs for approved or late-stage therapeutics
Deep domain knowledge in [oncology, rare disease, immunology, CNS, etc.] aligned with company pipeline
Strategic, pragmatic, and collaborative; able to balance scientific rigor with business needs
Exceptional communication and stakeholder management skills; able to influence internal and external audiences
Experience interacting directly with the FDA and other agencies; understanding of IND/NDA/BLA processes and commercial readiness
We blend global research excellence with U.S. execution agility. Our culture values purpose, transparency, and teamwork. The Chief Medical Officer must thrive in an environment where scientific integrity, commercial success, and patient impact go hand-in-hand. Cross-cultural collaboration and a solutions-focused mindset are essential for success.
| Base Salary Range | $415,000 – $470,000 |
| Performance Bonus | Up to 40–50% of base salary |
| Equity | Stock options or long-term incentive plan |
| Benefits | Full medical/dental/vision coverage, 401(k) with match, generous PTO, CME reimbursement |
| Location | [Boston / New York / Remote with travel as needed] |
This role is central to translating innovation into patient impact. You will help guide breakthrough therapies through development and approval while shaping how science serves public health.